Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.

Summaries of Product Characteristics 271 - 300 of 368
<  Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  12  13  |  Next 30   >
Package leaflet	Status for supply	Name of the medicinal product
PL	Resepti	Tramadol-Paracetamol KRKA 37.5 mg-325 mg tabletti, kalvopäällysteinen SPC 2024-06-26
PL	Resepti	Tramadol-Paracetamol KRKA 75 mg-650 mg tabletti, kalvopäällysteinen SPC 2024-06-26
PL	Resepti	Tramal 100 mg-ml tipat, liuos SPC 2024-07-17
PL	Resepti	Tramal 50 mg kapseli, kova SPC 2024-07-17
PL	Resepti	Tramal 50 mg liukeneva tabletti SPC 2024-07-17
PL	Resepti	Tramal 50 mg-ml injektioneste, liuos SPC 2024-07-17
PL	Resepti	Tramal Retard 50 mg, 100 mg, 150 mg, 200 mg depottabletti SPC 2024-08-01
PL	Resepti	Tramium 100 mg depotkapseli, kova SPC 2024-05-31
PL	Resepti	Tramium 150 mg depotkapseli, kova SPC 2024-05-31
PL	Resepti	Tramium 200 mg depotkapseli, kova SPC 2024-05-31
PL	Resepti	Trampalgin 37.5.-325 mg tabletti SPC 2019-06-20
PL	Resepti	Tranexamic acid Accord 100 mg-ml injektioneste, liuos SPC 2024-07-04
PL	Resepti	Tranexamic acid Alternova 100 mg-ml injektioneste, liuos SPC 2024-01-15
PL	Resepti	Tranexamic acid Baxter 100 mg-ml injektio-infuusioneste, liuos SPC 2020-06-02
PL	Resepti	Tranexamic acid Stragen 100 mg-ml injektio-infuusioneste, liuos SPC 2021-07-19
PL	Resepti	Transiderm-Nitro 5 mg-24 tuntia, 10 mg-24 tuntia depotlaastari SPC 2022-12-08
		European Medicines Agency's website: Translarna - EMA: EPAR PI Finnish Swedish
PL	Resepti	Trasylol 10 000 KIU-ml injektio - infuusioneste, liuos SPC 2024-03-25
		European Medicines Agency's website: Travatan - EMA: EPAR PI Finnish Swedish
PL	Resepti	Travoprost Stada 40 mikrog-ml silmätipat, liuos SPC 2021-08-18
PL	Resepti	Travoprost-Timolol STADA 40 mikrog-ml + 5 mg-ml silmätipat, liuos SPC 2020-07-22
		European Medicines Agency's website: Trazimera - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Trecondi - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Trelegy Ellipta - EMA: EPAR PI Finnish Swedish
		European Medicines Agency's website: Tremfya - EMA: EPAR PI Finnish Swedish
PL	Itsehoito	Treo 500 mg-50 mg poretabletti SPC 2024-01-03
PL	Resepti	Treosulfan Tillomed 5 g infuusiokuiva-aine, liuosta varten SPC 2020-09-09
PL	Resepti	Treposa 1 mg - ml infuusioneste, liuos SPC 2023-10-17
PL	Resepti	Treposa 10 mg - ml infuusioneste, liuos SPC 2023-10-17
PL	Resepti	Treposa 2,5 mg - ml infuusioneste, liuos SPC 2023-10-17
<  Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  12  13  |  Next 30   >